A Retrospective Follow-Up Study To Show The Effectiveness Of Booster Dose Of Foam Sclerotherapy Session At 3rd And...

Area of Science:

• Vascular Surgery
• Dermatology
• Phlebology

Background:

• Injection sclerotherapy is a recognized treatment for varicose vein disease.
• Varicose vein recurrence remains a clinical challenge.
• The study investigates the impact of booster doses on recurrence rates.

Purpose of the Study:

• To evaluate the efficacy of booster doses of injection sclerotherapy in reducing varicose vein recurrence.
• To assess the recurrence rates at 3 and 6 months post-initial treatment with booster sessions.

Main Methods:

• A cohort of 150 low-risk patients (ages 30-70) participated.
• Exclusion criteria included high-risk comorbidities, allergies, and specific vascular conditions.
• Booster Foam Sclerotherapy sessions were administered at 3 and 6 months, with outcomes documented.

Main Results:

• A 50% decrease in varicose vein recurrence was observed with booster injections.
• The procedure was conducted in an outpatient setting, requiring no specialized anesthesia.
• Booster doses at 3 and 6 months proved effective in managing recurrence.

Conclusions:

• Booster doses of injection sclerotherapy are effective in decreasing varicose vein recurrence.
• This treatment modality is suitable for outpatient management of low-risk patients.
• Further research may explore long-term efficacy and optimal timing of booster sessions.